Loading…

Aortic and Mitral Valve Replacement in a Patient with Hemophilia B

A 25-year-old man with factor IX deficiency had an aortic and mitral valve replacement using a 2M Starr Edwards valve in the mitral position and a 22 Medtronic valve in the aortic position under cover of factor IX concentrate. The surgical procedure and the immediate postoperative period were uneven...

Full description

Saved in:

Bibliographic Details
Published in:	Asian cardiovascular & thoracic annals 2007-12, Vol.15 (6), p.526-527
Main Authors:	Thankachen, Roy, George, Biju, Shukla, Vinayak, Korula, Roy J
Format:	Article
Language:	English
Subjects:	Acenocoumarol - therapeutic use Adult Anticoagulants - therapeutic use Aortic Valve - surgery Coagulants - administration & dosage Factor IX - administration & dosage Heart Valve Prosthesis Heart Valve Prosthesis Implantation - instrumentation Hemophilia B - complications Hemophilia B - drug therapy Hemophilia B - surgery Heparin - therapeutic use Humans Male Mitral Valve - surgery Prosthesis Design Rheumatic Heart Disease - complications Rheumatic Heart Disease - drug therapy Rheumatic Heart Disease - surgery Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c294t-b082159c35691248750c4c0af2cb2224dffe9b556779dea4b109b0d277f78e753
cites	cdi_FETCH-LOGICAL-c294t-b082159c35691248750c4c0af2cb2224dffe9b556779dea4b109b0d277f78e753
container_end_page	527
container_issue	6
container_start_page	526
container_title	Asian cardiovascular & thoracic annals
container_volume	15
creator	Thankachen, Roy George, Biju Shukla, Vinayak Korula, Roy J
description	A 25-year-old man with factor IX deficiency had an aortic and mitral valve replacement using a 2M Starr Edwards valve in the mitral position and a 22 Medtronic valve in the aortic position under cover of factor IX concentrate. The surgical procedure and the immediate postoperative period were uneventful except for a pericardial effusion which required a pericardiostomy. He was anticoagulated with heparin in the immediate postoperative period while the factor IX concentrate was being administered. Oral anticoagulation with acenocoumarol (Acitrom®) was started, maintaining the international normalized ratio between 1.5 and 2. He was doing well at follow-up 9 months later.
doi_str_mv	10.1177/021849230701500618
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68542496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_021849230701500618</sage_id><sourcerecordid>68542496</sourcerecordid><originalsourceid>FETCH-LOGICAL-c294t-b082159c35691248750c4c0af2cb2224dffe9b556779dea4b109b0d277f78e753</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMoun78AQ-Sk7fqJE2a9KjiFyiKqNcwTVM3krZr0lX897bsggfB0zDwvM8wLyGHDE4YU-oUONOi5DkoYBKgYHqDzJhmRSZzBZtkNgHZROyQ3ZTeASBnud4mO0yD4ErnM3J-1sfBW4pdTe_9EDHQVwyfjj65RUDrWtcN1HcU6SMOflq-_DCnN67tF3MfPNLzfbLVYEjuYD33yMvV5fPFTXb3cH17cXaXWV6KIatAcyZLm8uiZFxoJcEKC9hwW3HORd00rqykLJQqa4eiYlBWUHOlGqWdkvkeOV55F7H_WLo0mNYn60LAzvXLZAotBRdlMYJ8BdrYpxRdYxbRtxi_DQMzNWf-NjeGjtb2ZdW6-jeyrmoETldAwjdn3vtl7MZv_1dmq8Tcv82_fHQmtRjCeIAZTB477CYFk6Ywkhf5D_Ekg_c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68542496</pqid></control><display><type>article</type><title>Aortic and Mitral Valve Replacement in a Patient with Hemophilia B</title><source>Sage Journals Online</source><creator>Thankachen, Roy ; George, Biju ; Shukla, Vinayak ; Korula, Roy J</creator><creatorcontrib>Thankachen, Roy ; George, Biju ; Shukla, Vinayak ; Korula, Roy J</creatorcontrib><description>A 25-year-old man with factor IX deficiency had an aortic and mitral valve replacement using a 2M Starr Edwards valve in the mitral position and a 22 Medtronic valve in the aortic position under cover of factor IX concentrate. The surgical procedure and the immediate postoperative period were uneventful except for a pericardial effusion which required a pericardiostomy. He was anticoagulated with heparin in the immediate postoperative period while the factor IX concentrate was being administered. Oral anticoagulation with acenocoumarol (Acitrom®) was started, maintaining the international normalized ratio between 1.5 and 2. He was doing well at follow-up 9 months later.</description><identifier>ISSN: 0218-4923</identifier><identifier>EISSN: 1816-5370</identifier><identifier>DOI: 10.1177/021849230701500618</identifier><identifier>PMID: 18042783</identifier><language>eng</language><publisher>London, England: Asian Soc Cardio Surg</publisher><subject>Acenocoumarol - therapeutic use ; Adult ; Anticoagulants - therapeutic use ; Aortic Valve - surgery ; Coagulants - administration & dosage ; Factor IX - administration & dosage ; Heart Valve Prosthesis ; Heart Valve Prosthesis Implantation - instrumentation ; Hemophilia B - complications ; Hemophilia B - drug therapy ; Hemophilia B - surgery ; Heparin - therapeutic use ; Humans ; Male ; Mitral Valve - surgery ; Prosthesis Design ; Rheumatic Heart Disease - complications ; Rheumatic Heart Disease - drug therapy ; Rheumatic Heart Disease - surgery ; Treatment Outcome</subject><ispartof>Asian cardiovascular & thoracic annals, 2007-12, Vol.15 (6), p.526-527</ispartof><rights>2007 SAGE Publications</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c294t-b082159c35691248750c4c0af2cb2224dffe9b556779dea4b109b0d277f78e753</citedby><cites>FETCH-LOGICAL-c294t-b082159c35691248750c4c0af2cb2224dffe9b556779dea4b109b0d277f78e753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906,79113</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18042783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thankachen, Roy</creatorcontrib><creatorcontrib>George, Biju</creatorcontrib><creatorcontrib>Shukla, Vinayak</creatorcontrib><creatorcontrib>Korula, Roy J</creatorcontrib><title>Aortic and Mitral Valve Replacement in a Patient with Hemophilia B</title><title>Asian cardiovascular & thoracic annals</title><addtitle>Asian Cardiovasc Thorac Ann</addtitle><description>A 25-year-old man with factor IX deficiency had an aortic and mitral valve replacement using a 2M Starr Edwards valve in the mitral position and a 22 Medtronic valve in the aortic position under cover of factor IX concentrate. The surgical procedure and the immediate postoperative period were uneventful except for a pericardial effusion which required a pericardiostomy. He was anticoagulated with heparin in the immediate postoperative period while the factor IX concentrate was being administered. Oral anticoagulation with acenocoumarol (Acitrom®) was started, maintaining the international normalized ratio between 1.5 and 2. He was doing well at follow-up 9 months later.</description><subject>Acenocoumarol - therapeutic use</subject><subject>Adult</subject><subject>Anticoagulants - therapeutic use</subject><subject>Aortic Valve - surgery</subject><subject>Coagulants - administration & dosage</subject><subject>Factor IX - administration & dosage</subject><subject>Heart Valve Prosthesis</subject><subject>Heart Valve Prosthesis Implantation - instrumentation</subject><subject>Hemophilia B - complications</subject><subject>Hemophilia B - drug therapy</subject><subject>Hemophilia B - surgery</subject><subject>Heparin - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Mitral Valve - surgery</subject><subject>Prosthesis Design</subject><subject>Rheumatic Heart Disease - complications</subject><subject>Rheumatic Heart Disease - drug therapy</subject><subject>Rheumatic Heart Disease - surgery</subject><subject>Treatment Outcome</subject><issn>0218-4923</issn><issn>1816-5370</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMoun78AQ-Sk7fqJE2a9KjiFyiKqNcwTVM3krZr0lX897bsggfB0zDwvM8wLyGHDE4YU-oUONOi5DkoYBKgYHqDzJhmRSZzBZtkNgHZROyQ3ZTeASBnud4mO0yD4ErnM3J-1sfBW4pdTe_9EDHQVwyfjj65RUDrWtcN1HcU6SMOflq-_DCnN67tF3MfPNLzfbLVYEjuYD33yMvV5fPFTXb3cH17cXaXWV6KIatAcyZLm8uiZFxoJcEKC9hwW3HORd00rqykLJQqa4eiYlBWUHOlGqWdkvkeOV55F7H_WLo0mNYn60LAzvXLZAotBRdlMYJ8BdrYpxRdYxbRtxi_DQMzNWf-NjeGjtb2ZdW6-jeyrmoETldAwjdn3vtl7MZv_1dmq8Tcv82_fHQmtRjCeIAZTB477CYFk6Ywkhf5D_Ekg_c</recordid><startdate>200712</startdate><enddate>200712</enddate><creator>Thankachen, Roy</creator><creator>George, Biju</creator><creator>Shukla, Vinayak</creator><creator>Korula, Roy J</creator><general>Asian Soc Cardio Surg</general><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200712</creationdate><title>Aortic and Mitral Valve Replacement in a Patient with Hemophilia B</title><author>Thankachen, Roy ; George, Biju ; Shukla, Vinayak ; Korula, Roy J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c294t-b082159c35691248750c4c0af2cb2224dffe9b556779dea4b109b0d277f78e753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Acenocoumarol - therapeutic use</topic><topic>Adult</topic><topic>Anticoagulants - therapeutic use</topic><topic>Aortic Valve - surgery</topic><topic>Coagulants - administration & dosage</topic><topic>Factor IX - administration & dosage</topic><topic>Heart Valve Prosthesis</topic><topic>Heart Valve Prosthesis Implantation - instrumentation</topic><topic>Hemophilia B - complications</topic><topic>Hemophilia B - drug therapy</topic><topic>Hemophilia B - surgery</topic><topic>Heparin - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Mitral Valve - surgery</topic><topic>Prosthesis Design</topic><topic>Rheumatic Heart Disease - complications</topic><topic>Rheumatic Heart Disease - drug therapy</topic><topic>Rheumatic Heart Disease - surgery</topic><topic>Treatment Outcome</topic><toplevel>online_resources</toplevel><creatorcontrib>Thankachen, Roy</creatorcontrib><creatorcontrib>George, Biju</creatorcontrib><creatorcontrib>Shukla, Vinayak</creatorcontrib><creatorcontrib>Korula, Roy J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Asian cardiovascular & thoracic annals</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thankachen, Roy</au><au>George, Biju</au><au>Shukla, Vinayak</au><au>Korula, Roy J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aortic and Mitral Valve Replacement in a Patient with Hemophilia B</atitle><jtitle>Asian cardiovascular & thoracic annals</jtitle><addtitle>Asian Cardiovasc Thorac Ann</addtitle><date>2007-12</date><risdate>2007</risdate><volume>15</volume><issue>6</issue><spage>526</spage><epage>527</epage><pages>526-527</pages><issn>0218-4923</issn><eissn>1816-5370</eissn><abstract>A 25-year-old man with factor IX deficiency had an aortic and mitral valve replacement using a 2M Starr Edwards valve in the mitral position and a 22 Medtronic valve in the aortic position under cover of factor IX concentrate. The surgical procedure and the immediate postoperative period were uneventful except for a pericardial effusion which required a pericardiostomy. He was anticoagulated with heparin in the immediate postoperative period while the factor IX concentrate was being administered. Oral anticoagulation with acenocoumarol (Acitrom®) was started, maintaining the international normalized ratio between 1.5 and 2. He was doing well at follow-up 9 months later.</abstract><cop>London, England</cop><pub>Asian Soc Cardio Surg</pub><pmid>18042783</pmid><doi>10.1177/021849230701500618</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0218-4923
ispartof	Asian cardiovascular & thoracic annals, 2007-12, Vol.15 (6), p.526-527
issn	0218-4923 1816-5370
language	eng
recordid	cdi_proquest_miscellaneous_68542496
source	Sage Journals Online
subjects	Acenocoumarol - therapeutic use Adult Anticoagulants - therapeutic use Aortic Valve - surgery Coagulants - administration & dosage Factor IX - administration & dosage Heart Valve Prosthesis Heart Valve Prosthesis Implantation - instrumentation Hemophilia B - complications Hemophilia B - drug therapy Hemophilia B - surgery Heparin - therapeutic use Humans Male Mitral Valve - surgery Prosthesis Design Rheumatic Heart Disease - complications Rheumatic Heart Disease - drug therapy Rheumatic Heart Disease - surgery Treatment Outcome
title	Aortic and Mitral Valve Replacement in a Patient with Hemophilia B
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T17%3A55%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aortic%20and%20Mitral%20Valve%20Replacement%20in%20a%20Patient%20with%20Hemophilia%20B&rft.jtitle=Asian%20cardiovascular%20&%20thoracic%20annals&rft.au=Thankachen,%20Roy&rft.date=2007-12&rft.volume=15&rft.issue=6&rft.spage=526&rft.epage=527&rft.pages=526-527&rft.issn=0218-4923&rft.eissn=1816-5370&rft_id=info:doi/10.1177/021849230701500618&rft_dat=%3Cproquest_cross%3E68542496%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c294t-b082159c35691248750c4c0af2cb2224dffe9b556779dea4b109b0d277f78e753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68542496&rft_id=info:pmid/18042783&rft_sage_id=10.1177_021849230701500618&rfr_iscdi=true